- Home
- EVEX vs ETNB Comparison
EVEX vs ETNB Comparison
Compare EVEX & ETNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVEX
- ETNB
- Stock Information
- Founded
- EVEX 2020
- ETNB 2018
- Country
- EVEX United States
- ETNB United States
- Employees
- EVEX N/A
- ETNB N/A
- Industry
- EVEX Aerospace
- ETNB Biotechnology: Pharmaceutical Preparations
- Sector
- EVEX Industrials
- ETNB Health Care
- Exchange
- EVEX Nasdaq
- ETNB Nasdaq
- Market Cap
- EVEX 1.3B
- ETNB 1.2B
- IPO Year
- EVEX N/A
- ETNB 2019
- Fundamental
- Price
- EVEX $3.33
- ETNB $6.80
- Analyst Decision
- EVEX Strong Buy
- ETNB Strong Buy
- Analyst Count
- EVEX 3
- ETNB 10
- Target Price
- EVEX $6.00
- ETNB $27.56
- AVG Volume (30 Days)
- EVEX 249.4K
- ETNB 2.1M
- Earning Date
- EVEX 03-11-2025
- ETNB 05-08-2025
- Dividend Yield
- EVEX N/A
- ETNB N/A
- EPS Growth
- EVEX N/A
- ETNB N/A
- EPS
- EVEX N/A
- ETNB N/A
- Revenue
- EVEX N/A
- ETNB N/A
- Revenue This Year
- EVEX N/A
- ETNB N/A
- Revenue Next Year
- EVEX N/A
- ETNB N/A
- P/E Ratio
- EVEX N/A
- ETNB N/A
- Revenue Growth
- EVEX N/A
- ETNB N/A
- 52 Week Low
- EVEX $2.33
- ETNB $5.99
- 52 Week High
- EVEX $6.09
- ETNB $11.84
- Technical
- Relative Strength Index (RSI)
- EVEX 38.65
- ETNB 36.28
- Support Level
- EVEX $3.58
- ETNB $7.66
- Resistance Level
- EVEX $3.86
- ETNB $9.32
- Average True Range (ATR)
- EVEX 0.24
- ETNB 0.73
- MACD
- EVEX 0.03
- ETNB -0.12
- Stochastic Oscillator
- EVEX 39.08
- ETNB 3.59
About EVEX Eve Holding Inc.
Eve Holding Inc is a provider of Urban Air Mobility solutions. The company's operating segments are; eVTOL that includes; the design and production of electric vertical take-off and landing vehicles (eVTOLs) including fixed wing and helicopter operators, as well as lessors that purchase and manage aircraft on behalf of operators; Service and Operations Solutions segment which includes a portfolio of maintenance and support services focused on its and third-party eVTOLs; and the UATM segment , a new Urban Air Traffic Management system designed to allow eVTOLs to operate safely and efficiently in dense urban airspace alongside conventional aircraft and drones.
About ETNB 89bio Inc.
89bio Inc is a United States-based clinical-stage biopharmaceutical company focused on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its product candidate, pegozafermin (previously BIO89-100), a specifically engineered glycoPEGylated analog of fibroblast growth factor 21 (FGF21), is currently being developed for the treatment of nonalcoholic steatohepatitis (NASH) and for the treatment of severe hypertriglyceridemia (SHTG).